Follow
Hyunseok Kang
Title
Cited by
Cited by
Year
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE …
LQM Chow, R Haddad, S Gupta, A Mahipal, R Mehra, M Tahara, R Berger, ...
Journal of Clinical Oncology 34 (32), 3838, 2016
7362016
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung CancerDynamics of Neoantigen Landscape during Immunotherapy
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
Cancer discovery 7 (3), 264-276, 2017
6612017
Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...
Journal of Clinical Oncology 35 (14), 1542, 2017
5322017
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Y Wang, S Springer, CL Mulvey, N Silliman, J Schaefer, M Sausen, ...
Science translational medicine 7 (293), 293ra104-293ra104, 2015
4292015
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, ...
New England Journal of Medicine 383 (9), 825-835, 2020
3402020
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
R Mehra, TY Seiwert, S Gupta, J Weiss, I Gluck, JP Eder, B Burtness, ...
British journal of cancer 119 (2), 153-159, 2018
2962018
Emerging biomarkers in head and neck cancer in the era of genomics
H Kang, A Kiess, C Chung
Nature Reviews Clinical Oncology, 2014
2792014
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
CH Chung, VB Guthrie, DL Masica, C Tokheim, H Kang, J Richmon, ...
Annals of oncology 26 (6), 1216-1223, 2015
1622015
Head and neck PET/CT: therapy response interpretation criteria (Hopkins criteria)—interreader reliability, accuracy, and survival outcomes
C Marcus, A Ciarallo, AK Tahari, E Mena, W Koch, RL Wahl, AP Kiess, ...
Journal of Nuclear Medicine 55 (9), 1411-1416, 2014
1532014
Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method
G D’Souza, WH Westra, SJ Wang, A Van Zante, A Wentz, N Kluz, E Rettig, ...
JAMA oncology 3 (2), 169-177, 2017
1092017
Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity
L Rooper, K Theodoros, Y Ning, J Bishop, S Gordon, H Kang
American Journal of Surgical Pathology, 2018
762018
Whole-Exome Sequencing of Salivary Gland Mucoepidermoid CarcinomaWhole-Exome Sequencing of Salivary Mucoepidermoid Carcinoma
H Kang, M Tan, JA Bishop, S Jones, M Sausen, PK Ha, N Agrawal
Clinical Cancer Research 23 (1), 283-288, 2017
752017
High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer …
R Guerrero-Preston, JR White, F Godoy-Vitorino, A Rodríguez-Hilario, ...
Oncotarget 8 (67), 110931, 2017
682017
Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board
WB Dalton, PM Forde, H Kang, RM Connolly, V Stearns, CD Gocke, ...
JCO precision oncology 1, 1-19, 2017
662017
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study
R Kurzrock, DW Bowles, H Kang, F Meric-Bernstam, J Hainsworth, ...
Annals of Oncology 31 (3), 412-421, 2020
632020
Association between pretreatment lymphocyte count and response to PD1 inhibitors in head and neck squamous cell carcinomas
WJ Ho, M Yarchoan, A Hopkins, R Mehra, S Grossman, H Kang
Journal for ImmunoTherapy of Cancer 6, 84, 2018
612018
Salivary duct carcinoma: an aggressive salivary gland malignancy with opportunities for targeted therapy
NC Schmitt, H Kang, A Sharma
Oral oncology 74, 40-48, 2017
602017
Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
K Jung, H Kang, R Mehra
Cancers of the head & neck 3 (1), 1-13, 2018
582018
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer CellsSMAD4 Loss Induced Cetuximab Resistance in HNSCC
H Ozawa, RS Ranaweera, E Izumchenko, E Makarev, A Zhavoronkov, ...
Clinical Cancer Research 23 (17), 5162-5175, 2017
582017
Evaluation of proposed staging systems for human papillomavirus‐related oropharyngeal squamous cell carcinoma
IJ Malm, CJ Fan, LX Yin, DX Li, WM Koch, CG Gourin, KT Pitman, ...
Cancer 123 (10), 1768-1777, 2017
582017
The system can't perform the operation now. Try again later.
Articles 1–20